- Citations, last 5 years
- 356.5k
- Works, last 5 years
- 25.4k
- h-index
- 1,797
- Scientists listed
- 655
- Grants since 2016
- 3 144
Grants received
2017–2022 · career development · K08
Functional interrogation of epigenetic vulnerabilities in KRAS-mutant pancreatic cancer
Andrew James Aguirre · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2023 · research · R25
Summer Program to Advance Research Careers (SPARC)
Edward J Benz · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2022 · research · R25
Young Empowered Scientists for ContinUed Research Engagement (YES for CURE)
James A. Decaprio · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2022 · career development · K08
Improving Hospice Use for Patients with Blood Cancers
Oreofe Olukemi Odejide · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2022 · program · P50
SPORE in Myeloid Malignancies
Benjamin Levine Ebert · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2023 · cooperative agreement · U24
Cancer Immunologic Data Commons (CIDC) Supplement Request
Ethan Cerami · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2020 · research · R21
Primers: Combining Radiotherapy and Immunotherapy using next genertaion radiotherapy biomaterials
Wilfred Ngwa · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2019 · career development · K08
Transcriptional Regulation of the Androgen Receptor in Prostate Cancer
David Yoshio Takeda · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2019 · fellowship · F32
CDX2 regulation of anti-repressive enhancers in intestinal epithelium
Madhurima Saxena · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2022 · career development · K08
Improving Hospice Use for Patients with Blood Cancers
Oreofe Olukemi Odejide · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2022 · research · R25
Young Empowered Scientists for ContinUed Research Engagement (YES for CURE)
James A. Decaprio · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2023 · research · R01
MYB family alterations in pediatric gliomas
Rameen Beroukhim · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2021 · research · R01
Dissecting the Pathogenesis of Ewing Sarcoma with Integrative Genomics
Kimberly Stegmaier · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2020 · fellowship · F32
Characterization of genetic modifiers of bioenergetic rescue in mitochondrial disease cell lines
Christopher F. Bennett · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2021 · research · R01
Metabolic and Bioenergetic Control in Mitochondrial Diseases
Pere Puigserver · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2022 · research · R01
The molecular basis of IMiD induced neo-substrate recruitment to the CRL4CRBN ubiquitin E3 ligase.
Eric Sebastian Fischer · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2020 · fellowship · F32
Characterization of genetic modifiers of bioenergetic rescue in mitochondrial disease cell lines
Christopher F. Bennett · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2022 · grant · PCRP
Prostate Cancer Clinical Trials Consortium: Dana-Farber/Harvard Cancer Center
Mary-Ellen Taplin · Dana-Farber Cancer Institute · funded by Congressionally Directed Medical Research Programs
2017–2022 · program · P50
SPORE in Myeloid Malignancies
Benjamin Levine Ebert · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2021 · research · R01
Dissecting the Pathogenesis of Ewing Sarcoma with Integrative Genomics
Kimberly Stegmaier · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2022 · career development · K08
New Therapeutic Targets in Small Cell Lung Cancer that are Epistatic or Synthetic Lethal with pRB Loss
Matthew Gilbert Oser · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2022 · research · R01
Investigating 53BP1 'dephosphorylation' as a critical determinant of PARP
Dipanjan Chowdhury · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2021 · research · R33
Maximum efficiency sequencing using nuclease-based mutation enrichment and digital barcodes
G. Mike Makrigiorgos · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2027 · research · R01
Leveraging Novel Randomized Clinical Trials of Vitamin D Supplementation in Patients with Colorectal Cancer: Impact on Survival and Anti-Tumor Immunity
Kimmie Ng · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2022 · research · R01
Enhancing Global Diversity in Cancer Clinical Genetics
Jinbo Chen · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017 · research · Research
Comparing the Effect of Short-Course Versus Standard Radiation Therapy on Physical Well-Being Among Patients With Breast Cancer After a Mastectomy With Breast Reconstruction -- The FABREC Study
Rinaa S. Punglia · Dana-Farber Cancer Institute · funded by Patient-Centered Outcomes Research Institute
2017–2022 · research · R01
Dissecting the Pathogenesis of Ewing Sarcoma with Integrative Genomics
Kimberly Stegmaier · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2020 · fellowship · F32
Cross-species identification and validation of synthetic lethal relationships with VHL inactivation
Hilary Elaine Nicholson · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2021 · research · R01
Disseminating an Evidence-Based Tobacco Control intervention for School Teachers in India
Glorian C Sorensen · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2022 · research · R01
PediQUEST: Improving Children's Quality of Life through e-PROMS and Palliative Care
Joanne Wolfe · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2022 · research · R01
Unlocking the Potential of PI3K Inhibition in CLL
Jennifer R Brown · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2021 · research · R01
Disseminating an Evidence-Based Tobacco Control intervention for School Teachers in India
Glorian C Sorensen · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2022 · cooperative agreement · U01
Systematic interrogation of the pancreatic cancer microenvironment in patient-derived specimens
William C. Hahn · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2022 · research · R01
PediQUEST: Improving Children's Quality of Life through e-PROMS and Palliative Care (Diversity Supplement)
Joanne Wolfe · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2020 · fellowship · F32
Decoding PGC-1a1 Control of Energy Metabolism
Daniel Egan · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2022 · research · R01
The molecular basis of IMiD induced neo-substrate recruitment to the CRL4CRBN ubiquitin E3 ligase.
Eric Sebastian Fischer · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2024 · cooperative agreement · UG1
Safety and Feasibility of Cultivated Autologous Limbal Epithelial Cell (CALEC) Transplantation in the Treatment of Limbal Stem Cell Deficiency
Jerome Ritz · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2022 · research · R01
Prevention of HIV-1 transmission by small-molecule CD4-mimetic entry inhibitors
Navid Madani · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2022 · research · R01
Unlocking the Potential of PI3K Inhibition in CLL
Jennifer R Brown · Dana-Farber Cancer Institute · funded by National Institutes of Health
2017–2021 · research · R01
Dissecting the Pathogenesis of Ewing Sarcoma with Integrative Genomics
Kimberly Stegmaier · Dana-Farber Cancer Institute · funded by National Institutes of Health
